JPM 2026: How health systems are expanding clinical use of AI

Enrollment on health insurance exchanges is trending downward for 2026 as consumers confront sharply higher premiums and less generous financial assistance, reducing affordability. Falling sign-ups risk shrinking risk pools and increasing premium volatility, with potential negative implications for insurers' revenue trajectories and for fiscal exposure tied to subsidies.

Analysis

Market structure: Rapid premium inflation and smaller subsidies compress individual-market demand, creating clear winners (large diversified payers with scale and non‑exchange revenue like UNH, ELV, CVS) and losers (narrow, exchange‑centric carriers and regional hospitals). Expect enrollee count declines of 5–15% in 2026 in many states — pricing power shifts to incumbents who can reprice or exit markets; smaller carriers face adverse selection and capital stress. Net effect: concentration increases, margins polarize — winners see more predictable ARPU, losers see rising loss ratios and possible market exits.

Risk assessment: Tail risks include federal policy reversal (restoration of subsidies within 3–12 months) or emergency reinsurance programs that could restore enrollment — both would reprice winners down quickly. Near term (days–weeks) watch CMS weekly snapshots; short term (3–6 months) expect earnings revisions for exchange‑exposed insurers; long term (12–24 months) market consolidation and regulatory intervention are likely. Hidden dependencies: state Medicaid budgets, hospital bad‑debt carry and local election outcomes can transmit large second‑order shocks into P&Ls.

Trade implications: Prefer size and diversification — overweight UNH/ELV/CVS via call spreads to cap cost; underweight exchange‑centric names (small-cap carrier equities, regional hospital operators such as HCA) or buy protection via put spreads/CDS. Look to pair trades: long diversified payer, short exchange‑centric insurer to capture both consolidation and adverse‑selection divergence. Credit: wideners in regional hospital and small insurer bonds — buy protection in healthcare HY 3–5y bucket if spreads move +150bp.

Contrarian angles: Consensus assumes universal insurer pain; that is likely overdone — large payers can both raise list premiums and push more customers to employer/Medicare products, boosting EBITDA. Historical parallel: 2017 ACA subsidy debates caused short‑term enrollment swings but accelerated consolidation and higher equity multiples for scale players over 12–24 months. Unintended consequence: steep premium shock could trigger policy relief or M&A at rich takeover premiums, creating tactical buy targets among distressed small carriers.

Key Decisions for Investors

• Establish a 2–3% portfolio long position split UNH (ticker: UNH) 1.5% and Elevance (ELV) 1.5% via 3–6 month call spreads (buy 3% OTM, sell 6% OTM) to express pricing power and limit downside if subsidies are restored; target profit if spreads widen implied volatility falls >30% or stock up >15%.
• Initiate a 1–1.5% short/hedge vs exchange‑centric exposure: buy 3‑month put spreads on HCA (ticker: HCA) sized 1% (sell 5% OTM, buy 10% OTM) and equivalent exposure short CNC (Centene, ticker: CNC) equity or buy CNC 6‑month puts if enrollment decline >5% YoY in CMS snapshots over next 60 days.
• Put on a relative value pair trade: long UNH (1%) and short a small exchange‑focused insurer (1%, e.g., CNC or MOH depending on state mix) — increase size if state filings show premium increases >15% and enrollment down >7% by Nov 2025.
• Buy protection in credit: allocate 0.5–1% NAV to buy 3–5 year CDS protection or healthcare HY tranche protection to hedge against a 150–300bp widening in regional hospital/small insurer spreads; size up if municipal/state reinsurance signals are not announced within 90 days.
• Set explicit triggers to adjust: reduce long diversified insurer exposure by 50% if federal subsidy restoration is legislatively signaled within 3 months, or add to shorts if national exchange enrollment drop >7% YoY reported by CMS in any monthly release through Dec 2025.